secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001193125-26-031742
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA receives Nasdaq delisting notice for bid price below $1.00; 180-day cure period until July 2026
--------------------------------------------------------------------------------

- Nasdaq letter on Jan 29, 2026, for bid price <$1.00 for 35 consecutive days, violating Listing Rule 5550(a)(2).
- Company has 180-day grace period, until July 28, 2026, to regain compliance by closing bid price ≥$1.00 for 10 consecutive days.
- If not compliant by July 28, a second 180-day period may be available if other listing standards are met.
- Company will monitor bid price and consider options, including a potential reverse stock split to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526031742/0001193125-26-031742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526031742/hura-20260129.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-031742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer